This inventor holds 2 USPTO granted patents. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Brigitte Biesinger-Zwosta: Innovator in T-Lymphocyte Transformation
Introduction
Brigitte Biesinger-Zwosta is a notable inventor based in Uttenreuth, Germany. She has made significant contributions to the field of immunology, particularly in the transformation of human T-lymphocytes. With a total of 2 patents, her work has implications for both therapeutic applications and research.
Latest Patents
One of her latest patents focuses on the stable growth transformation of human T-lymphocytes by Herpesvirus. This invention involves infecting T-cells with strains of H. saimiri subgroup NonA NonB, preferably subgroup C. The transformed cells can grow independently of antigen stimulation and exhibit characteristics of activated mature T-lymphocytes. This process allows for the generation of human T-cell lines that can be utilized in various immunological and biochemical applications, as well as for therapeutic purposes. Another patent details a process for replicating HIV-type viruses using lymphocytes transformed with herpesvirus saimiri.
Career Highlights
Brigitte Biesinger-Zwosta is currently associated with Behringwerke Aktiengesellschaft, where she continues her innovative work in the field. Her research has contributed to advancements in understanding T-cell behavior and potential therapeutic applications.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues such as Bernhard W Fleckenstein and Sigrid Nick. These partnerships have further enriched her research and development efforts.
Conclusion
Brigitte Biesinger-Zwosta's contributions to the field of immunology through her patents and research are noteworthy. Her work in T-lymphocyte transformation has the potential to impact both scientific research and therapeutic practices significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile